Skip to main content
SpringerLink
Log in

Cord Blood Stem Cell Transplantation: Banking and Clinical Results

  • Conference paper
Cell Therapy

Part of the book series: Keio University Symposia for Life Science and Medicine ((KEIO,volume 5))

  • 84 Accesses

Summary

Since the demonstration that the number of hematopoietic stem cells contained in one cord blood was sufficient for engrafting children and adults, cord blood banking has developed worldwide. Cord blood banking for allogeneic unrelated and related transplants has several advantages including availability of this source of stem cells, low viral infection rate at birth, speed of search, and the possibility to collect cord blood in ethnic groups underrepresented in bone marrow donors registries. Another possible advantage includes the low risk of acute graft-versus-host disease (GVHD), even with some degree of HLA mismatch. Currently, more than 25 000 units are available for transplantation. To develop and evaluate cord blood transplant (CBT) results, the European Blood and Marrow Transplantation group (EBMT) has organized a concerted action, the Eurocord group. The objectives of Eurocord are to study the properties of hematopoietic progenitors and gene transfer in cord blood; to study the immune function of cord blood lymphocytes; to coordinate and facilitate the exchange of sera and cells from donor and recipients of cord blood transplants; to establish a European registry of patients treated by cord blood transplants; and to design protocols comparing cord blood transplants with alternative conventional blood and bone marrow hematopoietic stem cell transplants. Recently, Netcord, a nonprofit organization, was created for establishing criteria of qualification and accreditation of cord blood banks, and a network was set up between cord blood banks for facilitating donor search. The purpose is to ensure the quality of the cord blood units obtained for transplantation and to aid transplant centers in finding suitable units to increase the number of cord blood transplants (CBT) throughout the world. Briefly, recent analysis of the clinical results in 255 CBTs performed in 90 countries has shown that factors associated with better survival in related and unrelated transplants were younger age, diagnosis with better results in children with inborn errors, and acute leukemia in first and second remission. High numbers of nucleated cells in the transplant and recipient-negative CMV serology were also favorable risk factors for survival. The most important factor influencing engraftment was the number of cells infused.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Broxmeyer HE, Gordon GW, Hangoc G, et al (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86: 3828–3832

    Article  PubMed  CAS  Google Scholar 

  2. Broxmeyer HE, Hangoc G, Cooper S, et al (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109–4113

    Article  PubMed  CAS  Google Scholar 

  3. Mayani H, Lansdorp PM (1994) Thy-1 expression is linked to functional properties of primitive hematopoietic progenitors cells from human umbilical cord blood. Blood 83:2410–2417

    PubMed  CAS  Google Scholar 

  4. Morrison SJ, Wandycz AM, Akashi K, et al (1996) The aging of hematopoietic stem cells. Nat Med 2:1011–1016

    Article  PubMed  CAS  Google Scholar 

  5. Vaziri H, Dragowska W, Allsop RC, et al (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857–9860

    Article  PubMed  CAS  Google Scholar 

  6. Madrigal JA, Cohen SBA, Gluckman E, Charron DJ (1997) Does cord blood transplantation result in lower graft versus host disease? It takes more than two to tango. Hum Immunol 56:1–5

    Article  PubMed  CAS  Google Scholar 

  7. Garderet L, Dulphy N, Douay C, et al (1998) The umbilical cord blood all T cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 91:340–346

    PubMed  CAS  Google Scholar 

  8. Cairo MS, Wagner JE (1997) Placental and/or umbilical cord blood an alternative source of haemopoietic stem cells for transplantation. Blood 90:4665–4678

    PubMed  CAS  Google Scholar 

  9. De La Selle V, Gluckman E, Bruley-Rosset M (1996) Newborn blood can engraft adult mice without inducing graft versus host disease across non H-2 antigens. Blood 87:3977–3983

    Google Scholar 

  10. De La Selle V, Gluckman E, Bruley-Rosset M (1998) Graft versus host disease and graft versus leukemia effect in mice grafted with newborn blood. Blood 92:3968–3975

    Google Scholar 

  11. Rubinstein P, Rosenfield RD, Adamson JW, Stevens CE (1993) Stored placental blood for unrelated bone marrow reconstitution. Blood 81:1679–1690

    PubMed  CAS  Google Scholar 

  12. Rubinstein P, Dobrila L, Rosenfield RE, et al (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92:10119–10122

    Article  PubMed  CAS  Google Scholar 

  13. Gluckman E, Broxmeyer HE, Auerbach AD, et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLAidentical sibling. New Engl J Med 321:1174–1178

    Article  PubMed  CAS  Google Scholar 

  14. Sirchia G, Rebulla P, Lecchi L, Mozzi F, Crepaldi R, Parravicini A (1998) Implementation of a quality system (ISO 9000 series) for placental blood banking. J Hematother 7:19–35

    Article  PubMed  CAS  Google Scholar 

  15. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. New Engl J Med 334:1685–1690

    Article  PubMed  CAS  Google Scholar 

  16. Gluckman E (1995) Advantages of using fetal and neonatal cells for treatment of hematological diseases in human. In: Gluckman E, Coulombel L, (eds) Ontogeny of hematopoiesis: aplastic anemia. Colloque INSERM, vol 235. Libbey Eurotext, Paris, pp 183–190

    Google Scholar 

  17. Gluckman E, O’Reilly RJ, Wagner J, Rubinstein P (1996) Patents versus transplants. Nature (Lond) 382:108

    Article  CAS  Google Scholar 

  18. Sugarman J, Reisner EG, Kurtzberg J (1995) Ethical aspects of banking placental blood for transplantation. JAMA 275:1783–1785

    Article  Google Scholar 

  19. Sugarman J, Kaalund V, Kodish E, Marshall MF, Reisner EG, Wilfond BS, Wolpe PR (and the working group on ethical issues in umbilical cord blood banking) (1997) Ethical issues in umbilical cord blood banking. JAMA 278:938–943

    Article  PubMed  CAS  Google Scholar 

  20. Marshall E (1996) Private cord blood banks raise concern. Science 271:587

    Article  CAS  Google Scholar 

  21. Brenner M (1996) Placental blood transplant: who will benefit? Nat Med 2:969–970

    Article  PubMed  CAS  Google Scholar 

  22. Gluckman E (1996) The therapeutic potential of fetal and neonatal hematopoietic stem cells. New Engl J Med 335:1839–1840

    Article  PubMed  CAS  Google Scholar 

  23. Gluckman E, Rocha V, Boyer Chammard A, et al (1997) Outcome of cord blood transplantation from related and unrelated donors. New Engl J Med 337:373–381

    Article  PubMed  CAS  Google Scholar 

  24. Rocha V, Chastang CL, Souillet G, et al (for the Eurocord transplant group) (1998) Related cord blood transplants: the Eurocord experience of 78 transplants. Bone Marrow Transplant 21(suppl 3):S59–S65

    PubMed  Google Scholar 

  25. Locatelli F, Rocha V, Chastang C, et al (1998) Cord blood transplantation for children with acute leukemia. Bone Marrow Transplant 21(suppl 3):S66–S70

    Google Scholar 

  26. Miniero R, Rocha V, Saracco P, et al (on behalf of Eurocord) (1998) Cord blood transplantation in hemoglobinopathies. Bone Marrow Transplant 2(suppl 1):S78–S79

    Google Scholar 

  27. Rocha V, Chastang CL, Pasquini R, Nagler A, Gamier F, Saarinen U, Arcese W, Boiron JM, Stary J, Veyes P, Fernandez M, Milovic V, Akinoshita K, Favre C, Kremens B, Marin G, Gluckman E (1998) Cord blood transplant in bone marrow failure syndromes (abstract 547). Blood 92(10, suppl 1):136a

    Google Scholar 

  28. Gluckman E, Rocha V, Chastang C (1998) European results of unrelated cord blood transplants. Bone Marrow Transplant 21(suppl 3):S87–S91

    PubMed  Google Scholar 

  29. Rocha V, Chastang CL, Laporte JP, Garnier F, Fernandez M, Oteyza JP, Abecasis M, Gluckman E (1998) Unrelated cord blood transplant in adults with malignancies (abstract 580). Blood 92(10, suppl 1):144a

    Google Scholar 

  30. Kurtzberg J, Laughlin M, Graham L, et al (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Engl J Med 335:157–166

    Article  PubMed  CAS  Google Scholar 

  31. Wagner JE, Rosenthal J, Sweetman R, et al (1996) Successful transplantation of HLA matched and HLA mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft versus host disease. Blood 88:795–802

    PubMed  CAS  Google Scholar 

  32. Wagner JE, DeFor T, Rubinstein P, Kurtzberg J (1997) Transplantation of unrelated donor umbilical cord blood: outcomes and analysis of risk factors (abstract 1767). Blood 90(suppl 1):398a

    Google Scholar 

  33. Rubinstein P, Carrier C, Scaradavou A, et al (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New Engl J Med 339:1565–1577

    Article  PubMed  CAS  Google Scholar 

  34. Petit T, Dommergues M, Socié G, et al (1997) Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele specific PCR amplification. Br J Haematol 98:767–771

    Article  PubMed  CAS  Google Scholar 

  35. Socié G, Gluckman E, Carosella E, Brossard Y, Lafon C, Brison 0 (1994) Search for maternal cells in human cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 83:340–344

    PubMed  Google Scholar 

  36. Rocha V, Wagner J, Sobosinski K, Horowitz M, Guckman E (1998) Comparative study of graft versus host disease in HLA identical sibling cord blood or bone marrow transplant in children (abstract 2822). Blood 92(10, suppl 1):685a

    Google Scholar 

  37. Hongeng S, Krance RA, Bowman LC, et al (1997) Outcomes of transplantation with matched-sibling and unrelated donor bone marrow in children with leukemia. Lancet 350:767–771

    Article  PubMed  CAS  Google Scholar 

  38. Szydlo R, Goldman JM, Klein JP, et al (1997) Results of allogeneic bone marrow transplants for leukemia using donors other than HLA identical siblings. J Clin Oncol 15:1767–1777

    PubMed  CAS  Google Scholar 

  39. Oakhill A, Pamphilon DH, Potter MN, et al (1996) Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 94:574–578

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone Marrow Transplant Unit and Clinical Research Unit, Hopital Saint Louis, 1 Ave. Claude Vellefaux, 75475, Paris, Cedex 10, France

    V. Rocha & E. Gluckman

Authors
  1. V. Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Gluckman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku-ku, Tokyo, Japan

    Yasuo Ikeda M.D., Dr. Med. Sci. (Professor) & Yutaka Hattori M.D., Dr. Med. Sci. (Professor) & 

  2. Department of Pathology, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku-ku, Tokyo, Japan

    Jun-ichi Hata M.D., Dr. Med. Sci. (Professor) (Professor)

  3. Department of Microbiology, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku-ku, Tokyo, Japan

    Shigeo Koyasu Ph.D. (Professor) (Professor)

  4. Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku-ku, Tokyo, Japan

    Yutaka Kawakami M.D., Dr. Med. Sci. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Tokyo

About this paper

Cite this paper

Rocha, V., Gluckman, E. (2000). Cord Blood Stem Cell Transplantation: Banking and Clinical Results. In: Ikeda, Y., Hata, Ji., Koyasu, S., Kawakami, Y., Hattori, Y. (eds) Cell Therapy. Keio University Symposia for Life Science and Medicine, vol 5. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68506-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68506-7_21

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68508-1

  • Online ISBN: 978-4-431-68506-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation